Skip to content

Amphotericin B Liposome 50 mg Per Vial SIngle-Dose Vial 50 mg by Eugia (RX)

Brand: Eugia US
SKU: 55150-0365-01
Sale 55%
Original price $ 595.00
Current price $ 265.00
55% OFF
Free Shipping on orders above $120
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Payment Secure transaction
Packaging Ships in product packaging
Amphotericin B Liposome 50 mg Per Vial SIngle-Dose Vial 50 mg by Eugia (RX)
Sale 55%
Original price $ 595.00
Current price $ 265.00
Free Shipping on orders above $120
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Payment Secure transaction
Packaging Ships in product packaging
Description

Amphotericin B Liposome is an antifungal medication used for the treatment of serious fungal infections. It is a single-dose vial containing 50 mg of the medication. Amphotericin B Liposome works by disrupting the fungal cell membrane, killing the fungus and stopping its growth. It is typically only used for severe or life-threatening infections, and is administered intravenously by a healthcare professional. It may have potential side effects, such as fever, chills, nausea, and kidney damage, so it should only be used under medical supervision.

Amphotericin B Liposome is an injectable medication used to treat fungal infections. It is provided in single-dose vials containing 50 mg of the medication.

Advanced Antifungal Protection: Amphotericin B Liposome 50 mg by Eugia

Tackle severe, life-threatening fungal infections in clinical settings with Amphotericin B Liposome 50 mg Single-Dose Vial by Eugia (NDC: 55150-0365-01). This hospital-grade, liposomal encapsulated amphotericin B delivers potent broad-spectrum activity while significantly reducing the risk of kidney toxicity and infusion reactions compared to conventional amphotericin B formulations. Eugia’s commitment to pharmaceutical excellence ensures every vial delivers consistent, reliable performance for your most vulnerable patients.

Uses

  • Empiric Therapy for Febrile Neutropenia: First-line option for suspected invasive fungal infections in immunocompromised patients.
  • Confirmed Severe Mycoses: Treats systemic infections such as invasive aspergillosis, cryptococcal meningitis in HIV patients, candidiasis, histoplasmosis, blastomycosis, and mucormycosis.
  • Visceral Leishmaniasis: Effective for this parasitic infection, as per clinical protocol.

Benefits

  • Broad-Spectrum Efficacy: Active against a wide range of pathogenic fungi and molds.
  • Reduced Nephrotoxicity: Liposomal delivery minimizes renal damage and adverse effects, making it a safer option for high-risk patients.
  • Lower Infusion-Related Reactions: Improved patient tolerance compared to standard amphotericin B therapy.
  • Hospital-Trusted: Ideal for use in critical care, oncology, transplant, and infectious disease units.
  • Single-Dose Flexibility: Each 50 mg vial supports accurate, tailored dosing with minimal waste.
  • Eugia Quality Assurance: Manufactured to stringent standards for sterility, potency, and safety.

Specifications

Feature Detail
Product Name Amphotericin B Liposome
Strength 50 mg per vial (lyophilized powder)
Packaging Single-dose vial
NDC 55150-0365-01
Manufacturer Eugia US LLC
Route Intravenous (IV) infusion after reconstitution
Formulation Lyophilized sterile powder
Prescription Rx Only

 

Directions

For use under the supervision of qualified healthcare professionals only.

  1. Preparation:
    • Reconstitute each vial with 12 mL Sterile Water for Injection (do NOT use saline or bacteriostatic water).
    • Gently swirl (do not shake) until fully dissolved.
    • Further dilute the reconstituted solution in 5% Dextrose Injection (D5W).
  2. Administration:
    • Infuse intravenously over approximately 2 hours.
    • Usual adult dose: 3–5 mg/kg once daily for invasive fungal infections, adjusted per infection type, patient factors, and clinical response.
    • Always follow hospital, manufacturer, and clinical guidelines for exact dosing and infusion rates.
  3. Do not mix with sodium chloride solution or combine with other drugs.
  4. Monitor closely during infusion for hypersensitivity or infusion-related reactions.

Side Effects

Common Side Effects:

  • Chills, fever, back pain, headache during infusion
  • Nausea, vomiting
  • Low potassium or magnesium (electrolyte disturbances)
  • Mild, reversible kidney function changes

Serious/Rare Side Effects:

  • Severe infusion-related reactions (hypotension, chest pain, breathing difficulty)
  • Anaphylactic shock
  • Nephrotoxicity (rare, but possible)
  • Severe electrolyte imbalances
  • Liver toxicity

Notify medical staff immediately with signs of allergic reaction, severe shortness of breath, chest pain, or decreased urination.

Warnings

  • Prescription Hospital Use Only: To be reconstituted, diluted, and administered by trained medical professionals in an inpatient setting.
  • Monitor Renal and Hepatic Function: Regular lab checks for serum creatinine, electrolytes (especially potassium and magnesium), and liver enzymes are required.
  • Do Not Mix with Saline or Other Medications: Only use 5% dextrose for dilution and infusion.
  • Pregnancy & Pediatrics: Use only if benefits outweigh risks; closely monitor pregnant women, children, and frail or elderly patients.
  • Infusion Reactions: Premedicate or slow the infusion if patients have a history of infusion reactions or experience significant symptoms.

Why Choose Amphotericin B Liposome 50 mg by Eugia?

Amphotericin B Liposome 50 mg (NDC: 55150-0365-01) by Eugia combines the antifungal gold standard with the benefits of advanced liposomal delivery. For hospitals, infusion centers, and clinics demanding effective, patient-friendly, and safer antifungal care, Eugia’s solution delivers confidence, consistency, and results.

Order Amphotericin B Liposome 50 mg Single-Dose Vial by Eugia for advanced, low-toxicity treatment of invasive fungal infections.

 

Description

Amphotericin B Liposome is an antifungal medication used for the treatment of serious fungal infections. It is a single-dose vial containing 50 mg of the medication. Amphotericin B Liposome works by disrupting the fungal cell membrane, killing the fungus and stopping its growth. It is typically only used for severe or life-threatening infections, and is administered intravenously by a healthcare professional. It may have potential side effects, such as fever, chills, nausea, and kidney damage, so it should only be used under medical supervision.

Amphotericin B Liposome is an injectable medication used to treat fungal infections. It is provided in single-dose vials containing 50 mg of the medication.

Advanced Antifungal Protection: Amphotericin B Liposome 50 mg by Eugia

Tackle severe, life-threatening fungal infections in clinical settings with Amphotericin B Liposome 50 mg Single-Dose Vial by Eugia (NDC: 55150-0365-01). This hospital-grade, liposomal encapsulated amphotericin B delivers potent broad-spectrum activity while significantly reducing the risk of kidney toxicity and infusion reactions compared to conventional amphotericin B formulations. Eugia’s commitment to pharmaceutical excellence ensures every vial delivers consistent, reliable performance for your most vulnerable patients.

Uses

  • Empiric Therapy for Febrile Neutropenia: First-line option for suspected invasive fungal infections in immunocompromised patients.
  • Confirmed Severe Mycoses: Treats systemic infections such as invasive aspergillosis, cryptococcal meningitis in HIV patients, candidiasis, histoplasmosis, blastomycosis, and mucormycosis.
  • Visceral Leishmaniasis: Effective for this parasitic infection, as per clinical protocol.

Benefits

  • Broad-Spectrum Efficacy: Active against a wide range of pathogenic fungi and molds.
  • Reduced Nephrotoxicity: Liposomal delivery minimizes renal damage and adverse effects, making it a safer option for high-risk patients.
  • Lower Infusion-Related Reactions: Improved patient tolerance compared to standard amphotericin B therapy.
  • Hospital-Trusted: Ideal for use in critical care, oncology, transplant, and infectious disease units.
  • Single-Dose Flexibility: Each 50 mg vial supports accurate, tailored dosing with minimal waste.
  • Eugia Quality Assurance: Manufactured to stringent standards for sterility, potency, and safety.

Specifications

Feature Detail
Product Name Amphotericin B Liposome
Strength 50 mg per vial (lyophilized powder)
Packaging Single-dose vial
NDC 55150-0365-01
Manufacturer Eugia US LLC
Route Intravenous (IV) infusion after reconstitution
Formulation Lyophilized sterile powder
Prescription Rx Only

 

Directions

For use under the supervision of qualified healthcare professionals only.

  1. Preparation:
    • Reconstitute each vial with 12 mL Sterile Water for Injection (do NOT use saline or bacteriostatic water).
    • Gently swirl (do not shake) until fully dissolved.
    • Further dilute the reconstituted solution in 5% Dextrose Injection (D5W).
  2. Administration:
    • Infuse intravenously over approximately 2 hours.
    • Usual adult dose: 3–5 mg/kg once daily for invasive fungal infections, adjusted per infection type, patient factors, and clinical response.
    • Always follow hospital, manufacturer, and clinical guidelines for exact dosing and infusion rates.
  3. Do not mix with sodium chloride solution or combine with other drugs.
  4. Monitor closely during infusion for hypersensitivity or infusion-related reactions.

Side Effects

Common Side Effects:

  • Chills, fever, back pain, headache during infusion
  • Nausea, vomiting
  • Low potassium or magnesium (electrolyte disturbances)
  • Mild, reversible kidney function changes

Serious/Rare Side Effects:

  • Severe infusion-related reactions (hypotension, chest pain, breathing difficulty)
  • Anaphylactic shock
  • Nephrotoxicity (rare, but possible)
  • Severe electrolyte imbalances
  • Liver toxicity

Notify medical staff immediately with signs of allergic reaction, severe shortness of breath, chest pain, or decreased urination.

Warnings

  • Prescription Hospital Use Only: To be reconstituted, diluted, and administered by trained medical professionals in an inpatient setting.
  • Monitor Renal and Hepatic Function: Regular lab checks for serum creatinine, electrolytes (especially potassium and magnesium), and liver enzymes are required.
  • Do Not Mix with Saline or Other Medications: Only use 5% dextrose for dilution and infusion.
  • Pregnancy & Pediatrics: Use only if benefits outweigh risks; closely monitor pregnant women, children, and frail or elderly patients.
  • Infusion Reactions: Premedicate or slow the infusion if patients have a history of infusion reactions or experience significant symptoms.

Why Choose Amphotericin B Liposome 50 mg by Eugia?

Amphotericin B Liposome 50 mg (NDC: 55150-0365-01) by Eugia combines the antifungal gold standard with the benefits of advanced liposomal delivery. For hospitals, infusion centers, and clinics demanding effective, patient-friendly, and safer antifungal care, Eugia’s solution delivers confidence, consistency, and results.

Order Amphotericin B Liposome 50 mg Single-Dose Vial by Eugia for advanced, low-toxicity treatment of invasive fungal infections.

 

Get Notified When Back in Stock